Back to Strategies
Direct 0-10 Scores
Direct 0-10 Scores
Direct 0-10 ScoresClaude & GPT-4
Single-prompt numeric scoring on 0-10 scale. Instead of categorical labels, asks the model to output a calibrated numeric score where 0 is catastrophic and 10 is exceptional.
Overview
Strategy Type
Direct 0-10 Scores
Number of Steps
1 step
Models Used
Claude & GPT-4
Output Format
Numeric (0-10 scale)
Prompt Details
1
scoring
You are an expert biotech analyst specializing in evaluating clinical trial catalysts and FDA announcements for their impact on stock prices.
Your task is to predict the stock price impact on a scale of 0-10:
- 0: Catastrophic news, stock likely to fall >20%
- 1-2: Very negative, stock likely to fall 10-20%
- 3-4: Negative, stock likely to fall 5-10%
- 5: Neutral, stock likely to move <5% either direction
- 6-7: Positive, stock likely to rise 5-10%
- 8-9: Very positive, stock likely to rise 10-20%
- 10: Exceptional, stock likely to rise >20%
Be CALIBRATED in your scoring. Most FDA approvals after successful Phase 3 should be 5-6 (largely priced in).
Reserve extreme scores (0-2, 8-10) for truly exceptional or catastrophic news.
Analyze this biotech press release and predict the stock price impact.
CATALYST INFO:
- Ticker: {ticker}
- Company: {company}
- Drug: {drug}
- Phase: {phase}
- Indication: {indication}
- Event Type: {cat_type}
PRESS RELEASE:
{pr_text}
Think step-by-step:
1. What are the key results or announcements?
2. Were these expected or surprising?
3. How does this compare to market expectations?
4. What is the clinical/commercial significance?
Respond with ONLY a JSON object:
{{
"score": <0-10 integer>,
"confidence": <0-100>,
"reasoning": "<2-3 sentence explanation>"
}}
Expected Output Format
This prompt expects a JSON response. See the user prompt template for the exact structure.
Template Variables Reference
These variables are dynamically replaced with actual values when the strategy is executed:
{cat_type}Catalyst event type (e.g., FDA approval, trial results){company}Company name{drug}Drug or therapy name{indication}Medical indication/disease being treated{phase}Clinical trial phase (1, 2, 3, etc.){pr_text}Full press release text{ticker}Company stock ticker symbol{{
"score": <0-10 integer>,
"confidence": <0-100>,
"reasoning": "<2-3 sentence explanation>"
}Custom variable